However, in this study, the administered product was monocyte-derived dendritic cells loaded with frameshift-derived neoantigens of TGFBR2 and caspase-5, in addition to tumor-associated peptide carcinoembryonic antigen (CEA) [193]. The gene discussed is CEACAM5; the disease is neoplasm.